Literature DB >> 3724815

Instability of hematin used in the treatment of acute hepatic porphyria.

C A Goetsch, D M Bissell.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3724815     DOI: 10.1056/NEJM198607243150406

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  14 in total

Review 1.  Murine models of the human porphyrias: Contributions toward understanding disease pathogenesis and the development of new therapies.

Authors:  Makiko Yasuda; Robert J Desnick
Journal:  Mol Genet Metab       Date:  2019-01-18       Impact factor: 4.797

2.  Differential effects of metalloporphyrins on messenger RNA levels of delta-aminolevulinate synthase and heme oxygenase. Studies in cultured chick embryo liver cells.

Authors:  E E Cable; J A Pepe; N C Karamitsios; R W Lambrecht; H L Bonkovsky
Journal:  J Clin Invest       Date:  1994-08       Impact factor: 14.808

Review 3.  Management of attacks of acute porphyria.

Authors:  A C Laiwah; K E McColl
Journal:  Drugs       Date:  1987-11       Impact factor: 9.546

Review 4.  Erythropoietic and hepatic porphyrias.

Authors:  U Gross; G F Hoffmann; M O Doss
Journal:  J Inherit Metab Dis       Date:  2000-11       Impact factor: 4.982

Review 5.  Spotlight on Givosiran as a Treatment Option for Adults with Acute Hepatic Porphyria: Design, Development, and Place in Therapy.

Authors:  Chaudry Nasir Majeed; Christopher D Ma; Ted Xiao; Sean Rudnick; Herbert L Bonkovsky
Journal:  Drug Des Devel Ther       Date:  2022-06-16       Impact factor: 4.319

6.  Haem arginate improves hepatic oxidative metabolism in variegate porphyria.

Authors:  O Tokola; P Mustajoki; J J Himberg
Journal:  Br J Clin Pharmacol       Date:  1988-12       Impact factor: 4.335

7.  Effects of repeated intravenous administration of haem arginate upon hepatic metabolism of foreign compounds in rats and dogs.

Authors:  O Tokola
Journal:  Br J Pharmacol       Date:  1987-04       Impact factor: 8.739

8.  Differential regulation of human ALAS1 mRNA and protein levels by heme and cobalt protoporphyrin.

Authors:  Jianyu Zheng; Ying Shan; Richard W Lambrecht; Susan E Donohue; Herbert L Bonkovsky
Journal:  Mol Cell Biochem       Date:  2008-08-22       Impact factor: 3.396

9.  RNAi-mediated silencing of hepatic Alas1 effectively prevents and treats the induced acute attacks in acute intermittent porphyria mice.

Authors:  Makiko Yasuda; Lin Gan; Brenden Chen; Senkottuvelan Kadirvel; Chunli Yu; John D Phillips; Maria I New; Abigail Liebow; Kevin Fitzgerald; William Querbes; Robert J Desnick
Journal:  Proc Natl Acad Sci U S A       Date:  2014-05-12       Impact factor: 11.205

Review 10.  Acute Hepatic Porphyria.

Authors:  D Montgomery Bissell; Bruce Wang
Journal:  J Clin Transl Hepatol       Date:  2015-03-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.